ADCT ADC Therapeutics SA
Fundamentals / CIK 0001771910 / USDADC Therapeutics SA reported $84.87M in revenue and a net loss of $81.25M for the trailing twelve months ended September 30, 2026 (up 32.2% year over year), with a 89.0% gross margin and a -97.7% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ADCT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$84.87M +32.2% YoY
-
Operating Income TTM-$82.93M -97.7% margin
-
Net Income TTM-$81.25M -95.7% net margin
-
Diluted EPS TTM-$0.52 Split-adjusted
-
Free Cash Flow TTM-$100.5M -118.5% FCF margin
-
Cash & ST Investments Sep 30, 2026$189.2M Total debt: $7.80M
Annual revenue and net income
8 fiscal years (2018 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $81.36M | $70.84M | $69.56M | $209.9M | $33.92M | $0 | $2.34M | $1.14M |
| Cost of Revenue | $5.80M | $5.95M | $2.53M | $3.30M | $1.39M | $0 | $0 | -- |
| Gross Profit | $75.56M | $64.89M | $67.03M | $206.6M | $32.52M | $0 | $2.34M | -- |
| Research & Development | $104.0M | $109.6M | $127.1M | $186.5M | $158.0M | $142.0M | $107.5M | $118.3M |
| Selling, General & Admin | $79.93M | $85.91M | $105.9M | $143.5M | $136.2M | $77.23M | $14.20M | $8.77M |
| Total Operating Expenses | -- | -- | -- | $333.5M | $295.6M | $219.3M | $121.7M | $127.1M |
| Operating Income | -$121.5M | -$130.7M | -$166.0M | -$123.3M | -$261.7M | -$219.3M | -$119.4M | -$125.9M |
| EBITDA | -$120.8M | -$129.3M | -$164.8M | -$122.3M | -$260.7M | -$218.2M | -$118.8M | -$125.2M |
| Interest Income | $8.81M | $12.27M | $10.54M | $2.57M | $66K | $832K | $2.25M | $2.86M |
| Interest Expense | $51.63M | $50.21M | $46.33M | $36.73M | $18.34M | $4.93M | $156K | $0 |
| Income Before Tax | -$141.6M | -$156.1M | -$195.4M | -$146.8M | -$251.5M | -$246.0M | -$115.9M | -$122.9M |
| Income Tax Expense | $1.01M | $166K | $39.11M | $227K | -$21.48M | $327K | $582K | $224K |
| Net Income | -$142.6M | -$157.8M | -$240.1M | -$157.1M | -$230.0M | -$246.3M | -$116.5M | -$123.1M |
| Basic EPS | -$1.12 | -$1.62 | -$2.94 | -$2.01 | -$3.00 | -$3.77 | -$2.36 | -- |
| Diluted EPS | -$1.12 | -$1.62 | -$2.94 | -$2.01 | -- | -- | -- | -- |
| Basic Shares Outstanding | 127.1M | 97.2M | 81.7M | 78.2M | 76.7M | 65.4M | 49.3M | 46.6M |
| Diluted Shares Outstanding | 127.1M | 97.2M | 81.7M | 78.2M | 76.7M | 65.4M | 49.3M | 46.6M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.72M | $19.25M | $20.85M | $23.06M | $16.43M | $18.84M | $23.03M | $16.91M |
| Research & Development | $14.74M | $17.37M | $19.88M | $18.18M | $26.80M | $30.09M | $28.93M | $27.10M |
| Selling, General & Admin | $19.41M | $22.27M | $22.60M | $21.44M | $19.01M | $18.97M | $20.51M | $20.87M |
| Operating Income | -$14.35M | -$25.41M | -$25.25M | -$17.92M | -$30.97M | -$44.15M | -$28.46M | -$32.44M |
| EBITDA | -- | -- | -- | -$17.92M | -$30.97M | -$43.78M | -$28.12M | -$32.09M |
| Interest Income | $1.62M | $1.82M | $1.99M | $2.35M | $2.47M | $1.93M | $2.05M | $2.63M |
| Interest Expense | $13.73M | $13.51M | $12.35M | $13.01M | $13.39M | $13.00M | $12.23M | $11.92M |
| Income Before Tax | -$25.30M | -$16.57M | -$32.97M | -$6.81M | -$40.97M | -$55.39M | -$38.44M | -$31.05M |
| Income Tax Expense | $0 | $0 | $0 | -$404K | $0 | $1.25M | $165K | -$321K |
| Net Income | -$25.30M | -$16.57M | -$32.97M | -$6.41M | -$40.97M | -$56.65M | -$38.60M | -$30.73M |
| Basic EPS | -$0.16 | -$0.11 | -$0.21 | -- | -$0.30 | -$0.50 | -$0.36 | -- |
| Diluted EPS | -$0.16 | -$0.11 | -$0.21 | -- | -$0.30 | -$0.50 | -$0.36 | -- |
| Basic Shares Outstanding | 155.4M | 155.0M | 154.1M | -- | 136.4M | 113.7M | 107.2M | -- |
| Diluted Shares Outstanding | 155.4M | 155.0M | 154.1M | -- | 136.4M | 113.7M | 107.2M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $261.3M | $250.9M | $278.6M | $326.4M | $466.5M | $439.2M | $115.6M |
| Cash & Short-Term Investments | $261.3M | $250.9M | $278.6M | $326.4M | $466.5M | $439.2M | $115.6M |
| Accounts Receivable, Net | -- | -- | -- | $72.97M | $30.22M | $0 | -- |
| Inventory | $4.18M | $2.25M | $16.18M | $12.07M | $11.12M | $0 | -- |
| Other Current Assets | $6.08M | $9.45M | $5.99M | $28.04M | $17.30M | $11.26M | $7.05M |
| Total Current Assets | $306.3M | $291.3M | $336.3M | $435.0M | $525.2M | $450.4M | $122.6M |
| Property, Plant & Equipment, Net | $0 | $5.08M | $5.62M | $3.35M | $4.07M | $1.63M | $1.38M |
| Intangible Assets | -- | -- | -- | $14.36M | $13.58M | $10.18M | $8.43M |
| Other Non-Current Assets | $1.22M | $1.16M | $711K | $902K | $693K | $397K | $368K |
| Total Non-Current Assets | $16.82M | $30.73M | $18.49M | $83.15M | $92.79M | $63.24M | $15.08M |
| Total Assets | $323.1M | $322.0M | $354.8M | $490.9M | $618.0M | $513.7M | $137.7M |
| Accounts Payable | $9.18M | $18.03M | $15.57M | $12.35M | $12.08M | $5.28M | $3.33M |
| Short-Term Debt | $3.00M | $0 | -- | -- | $6.58M | $3.63M | $0 |
| Total Current Liabilities | $70.16M | $80.47M | $67.67M | $81.94M | $73.94M | $40.44M | $19.94M |
| Long-Term Debt | -- | -- | -- | -- | $87.15M | $34.77M | $0 |
| Other Non-Current Liabilities | $3.84M | $2.43M | $8.88M | $838K | $0 | $221K | $0 |
| Total Non-Current Liabilities | $438.8M | $444.2M | $435.4M | $341.5M | $377.9M | $137.8M | $6.58M |
| Total Liabilities | $509.0M | $524.6M | $503.0M | $411.4M | $451.9M | $178.2M | $26.53M |
| Total Debt (incl. Leases) | $4.57M | $9.37M | $11.65M | $7.66M | $101.8M | $41.87M | $5.03M |
| Common Stock | $11.08M | $8.43M | $7.31M | $7.31M | $6.45M | $6.31M | $4.36M |
| Retained Earnings | -$1.64B | -$1.49B | -$1.34B | -$1.10B | -$924.9M | -$694.9M | -$448.6M |
| Accumulated Other Comp. Income | -$517K | -$1.42M | -$93K | $1.82M | $102.6M | $42.75M | $5.47M |
| Total Stockholders' Equity | -$185.8M | -$202.6M | -$148.2M | $79.45M | $154.0M | $335.5M | $111.2M |
| Total Equity | -$185.8M | -$202.6M | -$148.2M | $79.45M | $154.0M | $335.5M | $111.2M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $189.2M | $219.1M | $231.0M | $261.3M | $234.7M | $264.6M | $194.7M | $250.9M |
| Cash & Short-Term Investments | $189.2M | $219.1M | $231.0M | $261.3M | $234.7M | $264.6M | $194.7M | $250.9M |
| Inventory | $5.63M | $4.93M | $4.78M | $4.18M | $18.04M | $17.76M | $17.45M | $2.25M |
| Other Current Assets | $3.19M | $4.25M | $4.26M | $6.08M | $5.52M | $5.66M | $7.18M | $9.45M |
| Total Current Assets | $238.6M | $261.7M | $276.8M | $306.3M | $287.1M | $318.8M | $258.0M | $291.3M |
| Property, Plant & Equipment, Net | -- | -- | -- | $0 | $0 | $1.0K | $5.16M | $5.08M |
| Other Non-Current Assets | $1.24M | $1.24M | $1.25M | $1.22M | $1.22M | $1.32M | $1.16M | $1.16M |
| Total Non-Current Assets | $17.29M | $17.67M | $14.73M | $16.82M | $2.61M | $2.81M | $14.55M | $30.73M |
| Total Assets | $255.9M | $279.4M | $291.5M | $323.1M | $289.8M | $321.6M | $272.5M | $322.0M |
| Accounts Payable | $5.58M | $12.76M | $5.29M | $9.18M | $8.12M | $9.62M | $15.59M | $18.03M |
| Short-Term Debt | $7.80M | $6.18M | $4.63M | $3.00M | -- | -- | -- | $0 |
| Total Current Liabilities | $78.12M | $86.33M | $67.63M | $70.16M | $62.04M | $64.60M | $57.79M | $80.47M |
| Other Non-Current Liabilities | $9.74M | $6.17M | $5.00M | $3.84M | $9.39M | $7.17M | $4.45M | $2.43M |
| Total Non-Current Liabilities | $426.9M | $421.3M | $440.2M | $438.8M | $465.9M | $456.1M | $453.0M | $444.2M |
| Total Liabilities | $505.0M | $507.6M | $507.9M | $509.0M | $527.9M | $520.7M | $510.8M | $524.6M |
| Total Debt (incl. Leases) | $7.80M | $7.13M | $5.63M | $4.57M | $2.06M | $3.05M | $9.28M | $9.37M |
| Common Stock | $11.26M | $11.25M | $11.23M | $11.08M | $9.76M | $9.75M | $8.44M | $8.43M |
| Retained Earnings | -$1.71B | -$1.69B | -$1.67B | -$1.64B | -$1.63B | -$1.59B | -$1.53B | -$1.49B |
| Accumulated Other Comp. Income | -$837K | -$814K | -$802K | -$517K | -$702K | -$388K | -$1.09M | -$1.42M |
| Total Stockholders' Equity | -$249.2M | -$228.2M | -$216.4M | -$185.8M | -$238.2M | -$199.2M | -$238.2M | -$202.6M |
| Total Equity | -$249.2M | -$228.2M | -$216.4M | -$185.8M | -$238.2M | -$199.2M | -$238.2M | -$202.6M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$142.6M | -$157.8M | -$240.1M | -$157.1M | -$230.0M | -$246.3M | -$116.5M | -$123.1M |
| Depreciation & Amortization | $705K | $1.33M | $1.19M | $1.06M | $1.05M | $1.04M | $582K | $740K |
| Stock-Based Compensation | $6.91M | $6.57M | $13.49M | $49.32M | $60.48M | $37.59M | $1.12M | $469K |
| Change in Receivables | -$8.79M | $4.77M | $47.79M | -$42.75M | -$30.22M | $0 | $192K | $895K |
| Change in Inventory | -$2.38M | -$3.73M | -$5.71M | -$9.65M | -$3.02M | $0 | $0 | -- |
| Change in Payables | -$9.04M | $2.46M | $3.17M | $310K | -- | -- | -- | -- |
| Operating Cash Flow | -$141.2M | -$123.8M | -$118.7M | -$138.3M | -$233.4M | -$168.7M | -$121.6M | -$121.4M |
| Capital Expenditure | -$264K | -$867K | -$3.22M | -$687K | -$3.43M | -$801K | -$358K | -$944K |
| Free Cash Flow | -$141.4M | -$124.7M | -$121.9M | -$139.0M | -$236.8M | -$169.5M | -$121.9M | -$122.3M |
| Investing Cash Flow | $395K | -$867K | -$3.22M | -$687K | -$6.67M | -$2.83M | -$2.25M | -$2.51M |
| Common Stock Issued | $86.28M | $60.51M | $0 | -- | $0 | $433.2M | $0 | $0 |
| Share Repurchases | -- | -- | -- | -- | $0 | $0 | -$141K | $0 |
| Financing Cash Flow | $150.9M | $97.05M | $73.88M | -$897K | $267.4M | $495.0M | $100.5M | -$24K |
| Net Change in Cash | $10.17M | -$27.65M | -$48.03M | -$139.9M | $27.34M | $323.4M | -$23.32M | -$123.9M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$25.30M | -$16.57M | -$32.97M | -$6.41M | -$40.97M | -$56.65M | -$38.60M | -$30.73M |
| Depreciation & Amortization | -- | -- | -- | $0 | $0 | $362K | $342K | $341K |
| Stock-Based Compensation | $4.09M | $4.55M | $2.44M | $673K | $2.00M | $1.81M | $2.42M | $1.62M |
| Change in Receivables | -$383K | $3.01M | -$1.93M | -$6.19M | $3.27M | $5.58M | -$11.45M | $3.71M |
| Change in Inventory | -$641K | -$3.29M | $16K | -$853K | -$516K | -$706K | -$306K | -$2.80M |
| Change in Payables | -$6.36M | $7.47M | -$3.87M | $932K | -$1.29M | -$6.22M | -$2.46M | $3.68M |
| Operating Cash Flow | -$27.88M | -$11.81M | -$29.71M | -$31.12M | -$29.63M | -$24.09M | -$56.33M | -$21.85M |
| Capital Expenditure | $0 | $0 | -$32K | $0 | $0 | $0 | -$264K | -$90K |
| Free Cash Flow | -$27.88M | -$11.81M | -$29.74M | -$31.12M | -$29.63M | -$24.09M | -$56.60M | -$21.94M |
| Investing Cash Flow | $0 | $0 | -$32K | $659K | $0 | $0 | -$264K | -$90K |
| Common Stock Issued | -$817K | $0 | -$20K | $43.52M | -$479K | $43.24M | $0 | -- |
| Financing Cash Flow | -$2.10M | -$99K | -$583K | $57.09M | -$198K | $93.78M | $271K | -$1.12M |
| Net Change in Cash | -$29.98M | -$11.91M | -$30.32M | $26.62M | -$29.83M | $69.70M | -$56.33M | -$23.06M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 92.9% | 91.6% | 96.4% | 98.4% | 95.9% | -- | 100.0% | -- |
| Operating Margin | -149.3% | -184.4% | -238.6% | -58.8% | -771.6% | -- | -5102.5% | -11047.5% |
| Net Profit Margin | -175.3% | -222.8% | -345.1% | -74.9% | -678.2% | -- | -4977.9% | -10797.9% |
| Return on Equity (ROE) | -- | -- | -- | -197.8% | -149.3% | -73.4% | -104.8% | -- |
| Return on Assets (ROA) | -44.1% | -49.0% | -67.7% | -32.0% | -37.2% | -47.9% | -84.6% | -- |
| Current Ratio | 4.37x | 3.62x | 4.97x | 5.31x | 7.10x | 11.14x | 6.15x | -- |
| Quick Ratio | 4.31x | 3.59x | 4.73x | 5.16x | 6.95x | 11.14x | 5.79x | -- |
| Debt to Equity | -- | -- | -- | 0.10x | 0.66x | 0.12x | 0.05x | -- |
| Revenue Growth (YoY) | +14.9% | +1.8% | -66.9% | +518.9% | -- | -100.0% | +105.3% | -- |
| Gross Profit Growth (YoY) | +16.4% | -3.2% | -67.6% | +535.2% | -- | -100.0% | -- | -- |
| 5Y Revenue / Share Growth | -- | +1435.4% | +3379.7% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -97.7% | -125.1% | -149.4% | -149.3% | -180.9% | -182.0% | -165.5% | -184.4% |
| Net Profit Margin | -95.7% | -121.8% | -173.0% | -175.3% | -222.0% | -220.0% | -197.6% | -222.8% |
| Return on Assets (ROA) | -31.8% | -34.7% | -47.0% | -44.1% | -57.6% | -52.8% | -55.0% | -49.0% |
| Current Ratio | 3.05x | 3.03x | 4.09x | 4.37x | 4.63x | 4.93x | 4.46x | 3.62x |
| Quick Ratio | 2.98x | 2.97x | 4.02x | 4.31x | 4.34x | 4.66x | 4.16x | 3.59x |
| Revenue Growth (YoY) | +32.2% | +2.2% | -9.5% | +36.4% | -11.0% | +8.2% | +27.6% | +0.7% |